Cargando…

Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

All antipsychotics currently used in clinic block D2 dopamine receptors. Trace amine-associated receptor 1 is emerging as a new therapeutic target for schizophrenia and several other neuropsychiatric disorders. SEP-363856 (International Nonproprietary Name: Ulotaront) is an investigational antipsych...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuvarzin, Savelii R., Sukhanov, Ilya, Onokhin, Kirill, Zakharov, Konstantin, Gainetdinov, Raul R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377193/ https://www.ncbi.nlm.nih.gov/pubmed/37509616 http://dx.doi.org/10.3390/biomedicines11071977

Ejemplares similares

Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders
por: Krasavin, Mikhail, et al.
Publicado: (2022)

Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-N-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders
por: Krasavin, Mikhail, et al.
Publicado: (2022)

Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma
por: Vaganova, Anastasia N., et al.
Publicado: (2022)

Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
por: Sukhanov, Ilya, et al.
Publicado: (2018)

Genetic Deletion of Trace-Amine Associated Receptor 9 (TAAR9) in Rats Leads to Decreased Blood Cholesterol Levels
por: Murtazina, Ramilya Z., et al.
Publicado: (2021)

Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
por: Heffernan, Michele L. R., et al.
Publicado: (2021)

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT(1A) Agonist, in Patients With Parkinson Disease Psychosis: A Pilot Study
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Public Transcriptomic Data Meta-Analysis Demonstrates TAAR6 Expression in the Mental Disorder-Related Brain Areas in Human and Mouse Brain
por: Vaganova, Anastasia N., et al.
Publicado: (2022)

Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
por: Aleksandrov, Aleksander A., et al.
Publicado: (2019)

Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
por: Espinoza, Stefano, et al.
Publicado: (2018)

Role of the trace amine associated receptor 5 (TAAR5) in the sensorimotor functions
por: Kalinina, D. S., et al.
Publicado: (2021)

Trace amine-associated receptors at the cross-road between innate olfaction of amines, emotions, and adult neurogenesis
por: Efimova, Evgeniya V., et al.
Publicado: (2021)

Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
por: Achtyes, Eric D., et al.
Publicado: (2023)

Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia
por: Galluppi, Gerald R., et al.
Publicado: (2021)

Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Trace Amine-Associated Receptor 5 Provides Olfactory Input Into Limbic Brain Areas and Modulates Emotional Behaviors and Serotonin Transmission
por: Espinoza, Stefano, et al.
Publicado: (2020)

Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice
por: Zhukov, Ilya S., et al.
Publicado: (2021)

Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis
por: Efimova, Evgeniya V., et al.
Publicado: (2022)

Expression of Trace Amine-Associated Receptors in the Murine and Human Hippocampus Based on Public Transcriptomic Data
por: Katolikova, Nataliia V., et al.
Publicado: (2022)

The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects
por: Cotter, Rachel, et al.
Publicado: (2015)

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics
por: Ågren, Richard, et al.
Publicado: (2023)

Novel translational rat models of dopamine transporter deficiency
por: Leo, Damiana, et al.
Publicado: (2018)

Trace Amine-Associated Receptors and Monoamine-Mediated Regulation of Insulin Secretion in Pancreatic Islets
por: Vaganova, Anastasia N., et al.
Publicado: (2023)

Improved cognitive performance in trace amine-associated receptor 5 (TAAR5) knock-out mice
por: Maggi, Silvia, et al.
Publicado: (2022)

In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT(1A) Receptor Agonist for the Treatment of Schizophrenia
por: Xiao, Guangqing, et al.
Publicado: (2022)

Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
por: Nicoli, Alessandro, et al.
Publicado: (2023)

Protein Metabolism Changes and Alterations in Behavior of Trace Amine-Associated Receptor 1 Knockout Mice Fed a High-Fructose Diet
por: Apryatin, Sergey A., et al.
Publicado: (2023)

Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1)
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease
por: Leo, Damiana, et al.
Publicado: (2022)

Expression Pattern of Trace Amine-Associated Receptors during Differentiation of Human Pluripotent Stem Cells to Dopaminergic Neurons
por: Katolikova, Nataliia V., et al.
Publicado: (2023)

Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS
por: Hopkins, Seth C., et al.
Publicado: (2021)

The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype
por: Vaganova, Anastasia N., et al.
Publicado: (2023)

Discovery of Novel Trace Amine-Associated Receptor 5 (TAAR5) Antagonists Using a Deep Convolutional Neural Network
por: Bon, Carlotta, et al.
Publicado: (2022)

Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays
por: Cichero, Elena, et al.
Publicado: (2023)

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
por: Chen, Yu-Luan, et al.
Publicado: (2023)

A randomized, single‐dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophrenia
por: Tsukada, Hironobu, et al.
Publicado: (2023)

Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
por: Savchenko, Artem, et al.
Publicado: (2023)

Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5
por: Dinter, Juliane, et al.
Publicado: (2015)

Incretin-like effects of small molecule trace amine-associated receptor 1 agonists
por: Raab, Susanne, et al.
Publicado: (2015)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2no3lodeamrh7buv6f7l70gstu